Cargando…

Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology

BACKGROUND: Differential diagnosis of systemic inflammatory response syndrome (SIRS) with or without infectious cause is critically important in terms of initiating antimicrobial agents in case of infectious etiology such as ventilator-associated pneumonia (VAP). The aim of this study was to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Salehifar, Ebrahim, Tavakolian Arjmand, Shima, Aliyali, Masoud, Abedi, Siavash, Sharifpour, Ali, Alipour, Abbas, Ala, Shahram, Eslami, Gohar, Bozorgi, Farzad, Mahdavi, Mohammad Reza, Walley, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Research Institute of Tuberculosis and Lung Disease 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410116/
https://www.ncbi.nlm.nih.gov/pubmed/28469676
_version_ 1783232609830043648
author Salehifar, Ebrahim
Tavakolian Arjmand, Shima
Aliyali, Masoud
Abedi, Siavash
Sharifpour, Ali
Alipour, Abbas
Ala, Shahram
Eslami, Gohar
Bozorgi, Farzad
Mahdavi, Mohammad Reza
Walley, Keith R.
author_facet Salehifar, Ebrahim
Tavakolian Arjmand, Shima
Aliyali, Masoud
Abedi, Siavash
Sharifpour, Ali
Alipour, Abbas
Ala, Shahram
Eslami, Gohar
Bozorgi, Farzad
Mahdavi, Mohammad Reza
Walley, Keith R.
author_sort Salehifar, Ebrahim
collection PubMed
description BACKGROUND: Differential diagnosis of systemic inflammatory response syndrome (SIRS) with or without infectious cause is critically important in terms of initiating antimicrobial agents in case of infectious etiology such as ventilator-associated pneumonia (VAP). The aim of this study was to determine the diagnostic and prognostic roles of C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α) in differentiating between ventilator-associated pneumonia and SIRS without infectious etiology. MATERIALS AND METHODS: In this prospective observational study, 91 adult intensive care unit (ICU) patients were enrolled. According to established diagnostic criteria, they were classified into three groups of “non-SIRS non-VAP”, “SIRS non-VAP” and “SIRS-VAP”. Serum CRP and TNF-α were measured on days 1, 3 and 7 of the study and compared using repeated measures ANOVA. RESULTS: With respect to diagnosis, there was no significant difference in the values of these biomarkers between groups (P>0.05). There was no statistically significant “time trend” for C-reactive protein and TNF-α (P>0.05). Considering both group effect and Time effect, the changes were not significantly different for CRP (P= 0.86) and TNF-α (P=0.69). In contrast, the clinical score and the clinical pulmonary infection score (CPIS) ≥ 6, had 100% specificity for diagnosing VAP. With respect to prognosis, only an unchanged or decreasing TNF-α from day 1 to day 3 was marginally associated with 28-day survival. However, day 1 and day 3 acute physiology and chronic health evaluation II (APACHE II) scores were highly associated with 28-day survival. CONCLUSION: Unlike clinical scoring system including CPIS and APACHE II, TNF-α and CRP levels were not useful as diagnostic or prognostic biomarkers for differentiating between SIRS with VAP etiology and SIRS without infectious etiology.
format Online
Article
Text
id pubmed-5410116
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher National Research Institute of Tuberculosis and Lung Disease
record_format MEDLINE/PubMed
spelling pubmed-54101162017-05-03 Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology Salehifar, Ebrahim Tavakolian Arjmand, Shima Aliyali, Masoud Abedi, Siavash Sharifpour, Ali Alipour, Abbas Ala, Shahram Eslami, Gohar Bozorgi, Farzad Mahdavi, Mohammad Reza Walley, Keith R. Tanaffos Original Article BACKGROUND: Differential diagnosis of systemic inflammatory response syndrome (SIRS) with or without infectious cause is critically important in terms of initiating antimicrobial agents in case of infectious etiology such as ventilator-associated pneumonia (VAP). The aim of this study was to determine the diagnostic and prognostic roles of C-reactive protein (CRP) and tumor necrosis factor-alpha (TNF-α) in differentiating between ventilator-associated pneumonia and SIRS without infectious etiology. MATERIALS AND METHODS: In this prospective observational study, 91 adult intensive care unit (ICU) patients were enrolled. According to established diagnostic criteria, they were classified into three groups of “non-SIRS non-VAP”, “SIRS non-VAP” and “SIRS-VAP”. Serum CRP and TNF-α were measured on days 1, 3 and 7 of the study and compared using repeated measures ANOVA. RESULTS: With respect to diagnosis, there was no significant difference in the values of these biomarkers between groups (P>0.05). There was no statistically significant “time trend” for C-reactive protein and TNF-α (P>0.05). Considering both group effect and Time effect, the changes were not significantly different for CRP (P= 0.86) and TNF-α (P=0.69). In contrast, the clinical score and the clinical pulmonary infection score (CPIS) ≥ 6, had 100% specificity for diagnosing VAP. With respect to prognosis, only an unchanged or decreasing TNF-α from day 1 to day 3 was marginally associated with 28-day survival. However, day 1 and day 3 acute physiology and chronic health evaluation II (APACHE II) scores were highly associated with 28-day survival. CONCLUSION: Unlike clinical scoring system including CPIS and APACHE II, TNF-α and CRP levels were not useful as diagnostic or prognostic biomarkers for differentiating between SIRS with VAP etiology and SIRS without infectious etiology. National Research Institute of Tuberculosis and Lung Disease 2016 /pmc/articles/PMC5410116/ /pubmed/28469676 Text en Copyright© 2016 National Research Institute of Tuberculosis and Lung Disease http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Salehifar, Ebrahim
Tavakolian Arjmand, Shima
Aliyali, Masoud
Abedi, Siavash
Sharifpour, Ali
Alipour, Abbas
Ala, Shahram
Eslami, Gohar
Bozorgi, Farzad
Mahdavi, Mohammad Reza
Walley, Keith R.
Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology
title Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology
title_full Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology
title_fullStr Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology
title_full_unstemmed Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology
title_short Role of C-reactive Protein and Tumor Necrosis Factor-Alpha in Differentiating between Ventilator-Associated Pneumonia and Systemic Inflammatory Response Syndrome without Infectious Etiology
title_sort role of c-reactive protein and tumor necrosis factor-alpha in differentiating between ventilator-associated pneumonia and systemic inflammatory response syndrome without infectious etiology
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410116/
https://www.ncbi.nlm.nih.gov/pubmed/28469676
work_keys_str_mv AT salehifarebrahim roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT tavakolianarjmandshima roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT aliyalimasoud roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT abedisiavash roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT sharifpourali roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT alipourabbas roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT alashahram roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT eslamigohar roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT bozorgifarzad roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT mahdavimohammadreza roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology
AT walleykeithr roleofcreactiveproteinandtumornecrosisfactoralphaindifferentiatingbetweenventilatorassociatedpneumoniaandsystemicinflammatoryresponsesyndromewithoutinfectiousetiology